As an associate editor on the ASCO Post editorial Board, Syed Ali Abutalib, MD, Assistant Medical Director of the Stem Cell Transplant and Cell Therapy Program at Cancer Treatment Centers of America® (CTCA), Chicago, provides regular updates and key findings, along with a fellow colleague, on clinical cancer research, policy news, patient care, and clinical practice issues.
In this review, the doctors share updates on several high-impact selected studies focusing on novel treatments for patients with newly diagnosed multiple myeloma presented at the 2018 American Society of Hematology (ASH) Annual Meeting & Exposition.
Read more here (Part 1)
Read more here (Part 2)